Five-year study revealed drug reduced strokes and cardiovascular events by 20%
The weightloss jab Wegovy can also reduce the risk of major cardiovascular events by 20% in people who are overweight or obese, the company behind the drug has said.
Wegovy – which is not yet available in the UK – has been hailed a wonder drug for weightloss, with the National Institute for Health and Care Excellence (Nice) saying patients on the weekly injections saw their weight fall by an average of 12%, compared with a placebo, after one year.
